These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26296493)

  • 1. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.
    Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C
    Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.
    Iwata S; Nakata S; Ukae S; Koizumi Y; Morita Y; Kuroki H; Tanaka Y; Shizuya T; Schödel F; Brown ML; Lawrence J
    Hum Vaccin Immunother; 2013 Aug; 9(8):1626-33. PubMed ID: 23732903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of rotavirus vaccine in the NICU.
    Monk HM; Motsney AJ; Wade KC
    Pediatrics; 2014 Jun; 133(6):e1555-60. PubMed ID: 24843056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination.
    Hofstetter AM; Lacombe K; Klein EJ; Jones C; Strelitz B; Jacobson E; Ranade D; Ward ML; Mijatovic-Rustempasic S; Evans D; Wikswo M; Bowen MD; Parashar UD; Payne DC; Englund JA
    Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29212881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjects.
    Lawrence J; He S; Martin J; Schödel F; Ciarlet M; Murray AV
    Hum Vaccin Immunother; 2014; 10(8):2247-54. PubMed ID: 25424929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for In-Neonatal Intensive Care Unit Administration of Live, Attenuated Rotavirus Vaccination.
    Briggs-Steinberg C; Shah S
    Am J Perinatol; 2018 Dec; 35(14):1443-1448. PubMed ID: 29883980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).
    Dennehy PH; Vesikari T; Matson DO; Itzler RF; Dallas MJ; Goveia MG; DiNubile MJ; Heaton PM; Ciarlet M
    Hum Vaccin; 2011 May; 7(5):563-8. PubMed ID: 21441783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
    Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
    Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
    Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
    Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.
    Levin MJ; Lindsey JC; Kaplan SS; Schimana W; Lawrence J; McNeal MM; Bwakura-Dangarembizi M; Ogwu A; Mpabalwani EM; Sato P; Siberry G; Nelson M; Hille D; Weinberg GA; Weinberg A
    AIDS; 2017 Jan; 31(1):49-59. PubMed ID: 27662551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Tolerance of In-Neonatal Intensive Care Unit Administration of Rotavirus Vaccine.
    Briggs-Steinberg C; Aboudi D; Hodson G; Shah S
    Am J Perinatol; 2021 Apr; 38(5):456-462. PubMed ID: 31739360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh.
    Feller AJ; Zaman K; Lewis KD; Hossain I; Yunus M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A101-5. PubMed ID: 22520118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
    Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States.
    Mast TC; Wang FT; Su S; Seeger JD
    Pediatr Infect Dis J; 2015 Jun; 34(6):615-20. PubMed ID: 25831421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
    Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
    Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.